首页> 美国卫生研究院文献>Nanotheranostics >Oxygen Self-Sufficient Amphiphilic Polypeptide Nanoparticles Encapsulating BODIPY for Potential Near Infrared Imaging-guided Photodynamic Therapy at Low Energy
【2h】

Oxygen Self-Sufficient Amphiphilic Polypeptide Nanoparticles Encapsulating BODIPY for Potential Near Infrared Imaging-guided Photodynamic Therapy at Low Energy

机译:氧气自足的两亲性多肽纳米粒子包封BODIPY可在低能量下进行潜在的近红外成像引导光动力疗法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Near infrared (NIR) imaging-guided photodynamic therapy (PDT) is remarkable for its high-efficiency in “see and treat” field. However, hypoxia of cancer cell limits PDT dues to the low singlet oxygen yield. Here MnO2 conjugated multifunctional polypeptide nanoparticles encapsulating photosensitizer BODIPY has been prepared via a one-step reaction, which can generate oxygen in cancer cytoplasm where rich of H2O2, following singlet oxygen by photosensitizer under NIR light irradiation. In vitro studies on HepG2 and 4T1 cancer cells revealed that the as-prepared nanoparticles obviously increase the cell suppression rate under hypoxia conditions, even exposed to an extremely low light energy density (25 mW/cm2). Meanwhile, excellent NIR fluorescence property of BODIPY enabled the nanoparticles to light up the cancer cells for real-time imaging. These results suggest the promises of biocompatible and biodegradable nanoparticles has potential application on efficient NIR imaging-guided photodynamic therapy.
机译:近红外(NIR)成像引导的光动力疗法(PDT)以其在“查看和治疗”领域的高效性而著称。但是,癌细胞的缺氧由于单线态氧产量低而限制了PDT。此处,通过一步反应制备了封装光敏剂BODIPY的MnO2共轭多功能多肽纳米粒子,该步骤可在近红外光照射下通过光敏剂产生单线态氧后,在富含H2O2的癌细胞质中产生氧气。对HepG2和4T1癌细胞的体外研究表明,即使暴露在极低的光能密度(25 mW / cm 2 )下,制备的纳米颗粒在缺氧条件下也明显提高了细胞抑制率。同时,BODIPY的出色NIR荧光特性使纳米粒子能够照亮癌细胞以进行实时成像。这些结果表明,生物相容性和可生物降解的纳米颗粒有望在有效的NIR成像引导的光动力疗法中应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号